Tag Archives: borden ladner gervais

Canadian Ruling Supports “Antibody Exception”

In my recent post on the Centocor v. Abbott decision, I noted that the Fed. Cir. had at least preserved the “antibody exception,” which I define as permitting broad claims to structurally uncharacterized antibodies (monoclonal and polyclonal) if the structure … Continue reading

Posted in Non-U.S. Practice | Tagged , , , , , , , , , , , | Leave a comment